Literature DB >> 6304228

Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.

W A Sewell, J J Munoz, M A Vadas.   

Abstract

Pertussigen, a purified protein from Bordetella pertussis, was shown to increase delayed-type hypersensitivity (DTH) to protein antigens in mice. First, it caused an approximately twofold enhancement of the magnitude of 24-h DTH reactions. Second, the peak magnitude of DTH was delayed to 4-7 d after challenge, at which time it was five times more intense than in mice not receiving pertussigen. This reaction was antigen specific, and histologically was characterized by a dense mononuclear infiltrate. Third, pertussigen prolonged DTH so that it was still detectable 3-6 wk after challenge. The effect of pertussigen was seen only in antigen-driven reactions and was time and dose dependent, with 400 ng given 3 d after immunization resulting in the most prolonged reaction. The administration of pertussigen to the recipients of sensitized lymph node cells resulted in DTH that was more intense and prolonged than the reactions in control mice. Administration of pertussigen provides a model of prolonged and enhanced T cell-dependent inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304228      PMCID: PMC2187035          DOI: 10.1084/jem.157.6.2087

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance.

Authors:  J W Moorhead
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

2.  Editorial: Delayed hypersensitivity and immunity in tuberculosis.

Authors:  M J Lefford
Journal:  Am Rev Respir Dis       Date:  1975-03

3.  Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen.

Authors:  T J Athanassiades
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity.

Authors:  K S Warren; E O Domingo; R B Cowan
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

5.  Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection.

Authors:  W F Green; D G Colley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

6.  Immunologic events in experimental hypersensitivity granulomas.

Authors:  E R Unanue; B Benacerraf
Journal:  Am J Pathol       Date:  1973-06       Impact factor: 4.307

7.  Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.

Authors:  R K Gershon; P W Askenase; M D Gershon
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

8.  Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.

Authors:  P H Lagrange; G B Mackaness; T E Miller
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

9.  Mechanisms of regulation of cell-mediated immunity. III. The characterization of azobenzenearsonate-specific suppressor T-cell-derived-suppressor factors.

Authors:  M I Greene; B A Bach; B Benacerraf
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

10.  Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis.

Authors:  R N Taub; W Rosett; A Adler; S I Morse
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  19 in total

1.  Influence of pertussis toxin on CD1a isoform expression in human dendritic cells.

Authors:  Angelo Martino; Elisabetta Volpe; Giovanni Auricchio; Vittorio Colizzi; Patrizia Morena Baldini
Journal:  J Clin Immunol       Date:  2006-04-06       Impact factor: 8.317

2.  Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays.

Authors:  P A De Moerloose; I H Frazer; W A Sewell; E J Collins; I R Mackay
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

3.  Mechanisms of genetic control of immune responses. II. Nonresponsiveness in BALB/c GT-specific cell-mediated immune responses does not correlate with the absence of functional T cells or the induction of suppressor T cells.

Authors:  M K Kennedy; M K Jenkins; S D Miller
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Inhibition of formation of cyclic AMP and cyclic GMP by vasopressin in smooth-muscle cells is insensitive to pertussis toxin.

Authors:  P Nambi; M Whitman; N Aiyar; S T Crooke
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

5.  Treatment of human platelets with trypsin, thrombin, or collagen inhibits the pertussis toxin-induced ADP-ribosylation of a 41-kDa protein.

Authors:  E G Lapetina; B Reep; K J Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Effect of pertussigen on inflammation caused by Freund adjuvant.

Authors:  J J Munoz; W A Sewell
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

7.  Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin.

Authors:  H H Mu; W A Sewell
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

8.  Experimental allergic orchitis in mice. II. Association of disease susceptibility with the locus controlling Bordetella pertussis-induced sensitivity to histamine.

Authors:  C Teuscher
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  A single nucleotide polymorphism in Tyk2 controls susceptibility to experimental allergic encephalomyelitis.

Authors:  Karen M Spach; Rajkumar Noubade; Ben McElvany; William F Hickey; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

10.  Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.

Authors:  J S Dhaliwal; F Y Liew
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.